Product manual
Product use, preparation, operating conditions and storage.
Label proteins, peptides and amino-modified molecules by coupling the NHS ester to accessible primary amines.
Packs & quoteThe NHS ester forms an amide bond with a primary amine; hydrolysis competes with coupling. Proteins usually contain multiple accessible sites, and the input ratio is not the final degree of labeling.
For samples with accessible primary amines. Check antigen binding, enzyme activity or the required function after purification.
Confirm the number and protection state of amino handles, then choose purification and analysis for the intended product.
Check the light source and filters against this product’s excitation and emission values. The number in the product name does not replace the actual wavelengths; recheck negative background and spillover after a channel or conjugate change.
Use parameters for the exact catalog number when preparing reagents, setting reagent input or calculating results. Request a lot-specific CoA for test results.
Avoid competing primary amines such as Tris, glycine and free amino acids. Remove carrier proteins such as BSA when they are not intended for labeling. Use a primary-amine-free buffer compatible with the sample.
Prepare the activated ester using a solvent supported for this product. Convert sample and dye amounts to moles using their molecular weights and record the final organic-solvent fraction.
Exchange into a suitable buffer and check concentration, purity, pH and visible aggregation.
Use a small sample to compare dye input ratios. Mix gently, protect from light and record pH, temperature and time. Select conditions from this product’s instructions and sample tolerance.
Select desalting, size-exclusion separation, dialysis or chromatography for the sample size. Remove free reagent before measuring concentration, labeling density and function. Residual free dye raises background and biases labeling-density calculations.
Calculate labeling density with appropriate extinction coefficients and absorbance corrections, then select conditions based on background, recovery and function.
Select a document and enter your phone and email. Include the lot number for a CoA.
Product use, preparation, operating conditions and storage.
Spectra, measurement conditions and detection settings for the exact catalog number.
Lot-specific test results. Include the lot number from the vial.
Handling, storage and emergency response information.
Use an unlabeled aliquot from the same preparation to assess changes in function, aggregation and recovery.
Include free-dye or no-target-handle controls to distinguish conjugation from adsorption. Match exposure, gain or voltage during detection.
Compare a molar input series and assess signal, negative background, product recovery and function together.
When comparing ATTO conjugates, use comparable target-protein amounts, labeling-density ranges and acquisition settings, recording specific binding, negative background and recovery.
Tris and glycine consume NHS dye. BSA and gelatin require separation from the target protein; routine buffer exchange is insufficient.
For protein preparation before NHS-ester labeling; check competing amines and carrier proteins.
Calculate DOL with absorbance correction, distinguish input ratio from attached dye, and assess recovery and binding.
For purified protein conjugates; use this dye’s absorbance parameters and distinguish input ratio from DOL.
Include your sample, formulation and detection method when requesting application guidance.
Nanda JS, Lorsch JR. · Methods in Enzymology · 536:87–94 · 2014
Uses FAM ester labeling of a protein to explain primary-amine chemistry and labeling-efficiency assessment. It informs NHS workflow design; input and reaction conditions depend on the actual dye and sample.
Vira S, Mekhedov E, Humphrey G, Blank PS. · Analytical Biochemistry · 402(2):146–150 · 2010
Uses FITC-labeled anti-HA antibody to assess changes in labeling density and antigen binding. It informs input-series design and post-purification functional testing; DOL alone is insufficient for selecting a conjugate.
ATTO-TEC / Leica Microsystems · ATTO Antibody Labeling Kit · 2025-03-19
Manufacturer IgG/NHS-ester example for preparation, purification and absorbance measurements. Its catalog numbers, spectral peaks, extinction coefficients and kit doses do not replace documentation for Qihe catalog numbers.
Routine NHS coupling requires an accessible primary amine. Confirm a suitable amino modification on the oligonucleotide.
Overlabeling can affect binding, solubility or signal. Assess specific signal, background and function after purification.
Activated esters hydrolyze in water. Use only the stock solvent, concentration and storage conditions supported for this product.
We use cookies and third-party analytics (Microsoft Clarity, Baidu Tongji, Google Analytics) to measure traffic and improve our service. Clarity includes session recording. You may decline — core site functionality is unaffected. View privacy policy